Skip to main content
NKMAX Co., Ltd. logo

NKMAX Co., Ltd. — Investor Relations & Filings

Ticker · 182400 ISIN · KR7182400002 KO Manufacturing
Open in API
Filings indexed 501 across all filing types
Latest filing 2025-12-30 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 182400

About NKMAX Co., Ltd.

https://nkmax.com/

NKMAX Co., Ltd. is a biotechnology company focused on developing immune-based solutions centered on Natural Killer (NK) cells. The company's primary focus is the development of adoptive cell therapies to treat incurable diseases, including cancer, autoimmune disorders, and neurodegenerative conditions. Its portfolio includes anti-cancer immunotherapy treatments and other biological products. In addition to therapeutics, NKMAX develops and markets a precision diagnostic test that measures NK cell activity. The company also manufactures and supplies specialized reagents, such as high-quality recombinant proteins and antibodies, for biotechnology research, as well as a line of health functional foods designed to support the immune system.

Recent filings

Filing Released Lang Actions
증권발행결과(자율공시) (제3자배정 유상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from NKMAX regarding the results of a third-party capital increase (share issuance) via debt-to-equity conversion. It details the number of shares issued, the amount, and the payment date. This falls under the category of share issuance and capital changes.
2025-12-30 Korean
[기재정정]주요사항보고서(감자결정)
Share Issue/Capital Change Classification · 95% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities (Financial Services Commission/Korea Exchange) regarding a capital reduction (감자 결정). It is an amendment (정정신고) to a previously filed report, updating the schedule for the capital reduction. Since this relates to a significant corporate action involving capital structure changes (capital reduction/share adjustment) and does not fit into specific categories like M&A or share buybacks, it is classified as a regulatory filing.
2025-12-22 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Korea Exchange regarding a decision for a third-party allocation capital increase (유상증자결정) due to a debt-to-equity swap (출자전환) following a rehabilitation process. This document details the issuance of new shares, the purpose of the capital increase, and the specific allocation to creditors. Since it involves the issuance of new shares and changes to the company's capital structure, it falls under the 'Share Issue/Capital Change' category.
2025-12-17 Korean
[기재정정]주주총회소집결의 (임시주주총회)
AGM Information Classification · 95% confidence The document is a detailed announcement regarding the convening of a shareholders' meeting (임시주주총회, or extraordinary general meeting) including the date, location, agenda items such as director and auditor appointments, capital changes, and other corporate governance matters. It includes specifics about the nomination and appointment of new directors and auditors, which is typical content for a shareholder meeting notice. The document is not a report of voting results, nor is it a full annual or interim financial report. It is not a proxy solicitation or remuneration report. The document is primarily about the resolution to convene the shareholders' meeting and the agenda to be discussed. Therefore, it fits best under the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or other shareholder meetings. The document length is 3562 characters, which is consistent with a meeting notice rather than a full report.
2025-11-06 Korean
[기재정정]주주총회소집공고
AGM Information Classification · 95% confidence The document is a detailed announcement related to a shareholders' meeting, specifically a notice of convocation for an extraordinary general meeting (임시주주총회) including agenda items such as election of directors, amendments to articles of incorporation, and capital reduction. It includes detailed information about candidates for outside director positions, their backgrounds, and related confirmations. The document also contains information about the company's business overview and governance-related details. The presence of detailed agenda items for a shareholders' meeting and the notice of convocation indicates this is a formal announcement to shareholders about the meeting. It is not the actual minutes or results of the meeting, nor is it a full annual report or financial statement. The document is lengthy (15,000 characters) and contains substantive content about the meeting agenda and candidate details, which aligns with the category of AGM Information (AGM-R). Therefore, the document is best classified as AGM Information (AGM-R).
2025-11-06 Korean
소송등의판결ㆍ결정(일정금액이상의청구)
Legal Proceedings Report Classification · 95% confidence The document is a legal announcement regarding a court decision on a significant lawsuit involving the company 엔케이맥스. It details the case name, parties involved, decision content, amounts, and legal context. The document does not contain financial statements or management discussion but focuses on legal proceedings and their implications. It is not an annual or interim report, nor a financial supplement or earnings release. It is clearly an update on a legal matter involving the company, fitting the category of Legal Proceedings Report (LTR). The document length is short and focused on legal content, not a report publication or certification. Therefore, the appropriate classification is LTR with high confidence.
2025-11-06 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.